« MediaWiki:ContentImporter-wikidoc-postponed.json » : différence entre les versions
(Ajout item reporté) |
(Ajout item reporté) |
||
(146 versions intermédiaires par 3 utilisateurs non affichées) | |||
Ligne 1 : | Ligne 1 : | ||
[ | [ | ||
"11β-hydroxylase deficiency (patient information)", | "11β-hydroxylase deficiency (patient information)", | ||
"Abdominal enlargement", | "Abdominal enlargement", | ||
"Abdominal pain", | "Abdominal pain", | ||
"Accommodative insufficiency", | "Accommodative insufficiency", | ||
"Acid indigestion", | "Acid indigestion", | ||
Ligne 18 : | Ligne 9 : | ||
"Anosmia", | "Anosmia", | ||
"Anxiety", | "Anxiety", | ||
"16PF Questionnaire", | "16PF Questionnaire", | ||
"16 Personality Factors", | "16 Personality Factors", | ||
Ligne 32 : | Ligne 22 : | ||
"Acoustic reflex", | "Acoustic reflex", | ||
"Actigraphy", | "Actigraphy", | ||
"Acute brachial neuritis" | "Acute brachial neuritis", | ||
"Acute brachial neuritis electromyogram", | |||
"Acute disseminated encephalomyelitis", | |||
"Advanced sleep phase syndrome", | |||
"Abdominal distension", | |||
"2nd Skin", | |||
"3,3'-Diiodothyronine", | |||
"3,4-Diaminopyridine", | |||
"3,4-Methylenedioxyamphetamine", | |||
"3-Methylglutaconic aciduria", | |||
"Arthralgia", | |||
"3 hydroxyisobutyric aciduria", | |||
"3 methylcrotonic aciduria", | |||
"3c syndrome", | |||
"3m syndrome", | |||
"48, XXXX", | |||
"48, XXYY", | |||
"49, XXXXX", | |||
"49 XXXXY syndrome", | |||
"5-HT1A receptor", | |||
"5-HT1B receptor", | |||
"5-HT1D receptor", | |||
"5-HT1E receptor", | |||
"5-HT1F receptor", | |||
"5-HT1 receptor", | |||
"5-HT2A receptor", | |||
"5-HT2B receptor", | |||
"5-HT2C receptor", | |||
"5-HT2 receptor", | |||
"5-HT3", | |||
"5-HT3 antagonist", | |||
"5-HT3 receptor", | |||
"5-HT4 receptor", | |||
"5-HT5A receptor", | |||
"5-HT6 receptor", | |||
"5-HT7 receptor", | |||
"5-HT receptor", | |||
"5-alpha-reductase deficiency", | |||
"5-alpha-reductase inhibitor", | |||
"5q- syndrome", | |||
"8-Aminoquinoline", | |||
"9q34 deletion syndrome", | |||
"Aura (symptom)", | |||
"Back pain", | |||
"Akathisia", | |||
"Abdominal aortic aneurysm", | |||
"Abdominal aortic aneurysm natural history", | |||
"Hypereosinophilia", | |||
"Abnormal cardiac rhythm", | |||
"Abarelix", | |||
"Emergency medicine", | |||
"Abdominal pain critical pathways", | |||
"Abdominal pain duration critical pathways", | |||
"Borborygmus", | |||
"A-a gradient", | |||
"Bradycardia", | |||
"Brain freeze", | |||
"Brain zap", | |||
"ABC (medical)", | |||
"ABO blood group system", | |||
"ABVD", | |||
"ACC-2017 Pregnancy - CHD", | |||
"ACC/AHA guidelines-recommendations for permanent pacing in patients with congenital heart disease", | |||
"ACE inhibitor", | |||
"ACGT", | |||
"ACUITY HORIZONS bleeding criteria", | |||
"ACVBP-R regimen", | |||
"Abdominal bruit", | |||
"AC regimen", | |||
"AD-36", | |||
"ADHD predominantly inattentive", | |||
"ADOC regimen", | |||
"AFP-L3", | |||
"AIDS-related complex", | |||
"AIDS-related lymphoma", | |||
"AIDS Clinical Trials Group", | |||
"AIDS defining clinical condition", | |||
"AIDS dementia complex", | |||
"AMPA receptor", | |||
"ANCA associated vasculitis", | |||
"ANDEXXA", | |||
"AP (Anterior-Posterior)", | |||
"ASHICE", | |||
"ATPase", | |||
"AVNRT Slow/Fast", | |||
"AVNRT Slow/Slow", | |||
"AVPU", | |||
"AV Conduction", | |||
"AV junctional rhythms", | |||
"AV nodal ablation", | |||
"AV nodal reentrant tachycardia", | |||
"AV reentrant tachycardia", | |||
"Abacavir", | |||
"Abacavir (Patient Information)", | |||
"Abacavir adverse reactions", | |||
"Abacavir clinical pharmacology", | |||
"Abacavir clinical studies", | |||
"Abacavir contraindications", | |||
"Abacavir description", | |||
"Abacavir dosage and administration", | |||
"Abacavir how supplied", | |||
"Abacavir indications and usage", | |||
"Abacavir lamivudine", | |||
"Abacavir lamivudine adverse reactions", | |||
"Abacavir lamivudine clinical pharmacology", | |||
"Abacavir lamivudine contraindications", | |||
"Abacavir lamivudine description", | |||
"Abacavir lamivudine dosage and administration", | |||
"Abacavir lamivudine drug interactions", | |||
"Abacavir lamivudine how supplied", | |||
"Abacavir lamivudine indications and usage", | |||
"Abacavir lamivudine overdosage", | |||
"Abacavir lamivudine microbiology", | |||
"Abacavir lamivudine warnings and precautions", | |||
"Abacavir lamivudine zidovudine", | |||
"Abacavir lamivudine zidovudine adverse reactions", | |||
"Abacavir lamivudine zidovudine clinical pharmacology", | |||
"Abacavir lamivudine zidovudine contraindications", | |||
"Abacavir lamivudine zidovudine description", | |||
"Abacavir lamivudine zidovudine dosage and administration", | |||
"Abacavir lamivudine zidovudine drug interactions", | |||
"Abacavir lamivudine zidovudine how supplied", | |||
"Abacavir lamivudine zidovudine indications and usage", | |||
"Abacavir lamivudine zidovudine microbiology", | |||
"Abacavir lamivudine zidovudine overdosage", | |||
"Abacavir lamivudine zidovudine warnings and precautions", | |||
"Abacavir microbiology", | |||
"Abacavir overdosage", | |||
"Abacavir warnings and precautions", | |||
"Abagovomab", | |||
"Abatacept", | |||
"Abciximab", | |||
"Abderhalden-Kaufmann-Lignac syndrome", | |||
"Abdominal CSF pseudocyst", | |||
"Abdominal X-ray", | |||
"Abdominal angina", | |||
"Abdominal aorta", | |||
"Abdominal aortic aneurysm diagnostic study of choice", | |||
"Abdominal aortic plexus", | |||
"Abdominal cutaneous nerve entrapment syndrome", | |||
"Abdominal external oblique muscle", | |||
"Abdominal hair", | |||
"Abdominal internal oblique muscle", | |||
"Abdominal parasitic infection", | |||
"Abdominal wall defect", | |||
"Breast lumps" | |||
] | ] |
Dernière version du 25 mars 2020 à 20:17
|